Natalizumab Completed Phase N/A Trials for Relapsing Remitting Multiple Sclerosis (RRMS)

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02677077Clinical Disease Activity With Long Term Natalizumab Treatment
NCT02159573Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)
NCT01943526Ireland Natalizumab (TYSABRI) Observational Program
NCT00818038A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function